Boehringer Ingelheim India has signed a memorandum of understanding (MoU) to enhance pharmaceutical education and research collaboration.
STA is now the only Chinese contract manufacturing organization to have received approval to supply active pharmaceutical ingredients (APIs) and GMP intermediates for branded commercial drugs from regulatory
The 12-month option provides an additional $2.1 million to Soligenix to advance OrbeShield™ as a medical countermeasure (MCM) for the treatment of gastrointestinal acute radiation syndrome (GI ARS).
The proprietary synthetic molecules called Antibody Recruiting Molecules (ARMs) are developed by professor David Spiegel and his team at Yale University. The ARMs work by harnessing the power
Tarloxotinib is the company’s hypoxia-activated, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor licensed from the University of Auckland, New Zealand. The company noted that elevated expression
Earlier, the FDA has approved Jardiance (empagliflozin) and Glyxambi (empagliflozin/linagliptin), while Synjardy is the third product containing empagliflozin that received approval from the agency. Both empagliflozin and metformin
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.
